169 related articles for article (PubMed ID: 18398596)
1. [Bladder carcinoma cell lines as models of the pathobiology of bladder cancer. Review of the literature and establishment of a new progression series].
Hatina J; Huckenbeck W; Rieder H; Seifert HH; Schulz WA
Urologe A; 2008 Jun; 47(6):724-34. PubMed ID: 18398596
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation.
Greife A; Tukova J; Steinhoff C; Scott SD; Schulz WA; Hatina J
Tumour Biol; 2015 May; 36(5):3293-300. PubMed ID: 25566959
[TBL] [Abstract][Full Text] [Related]
4. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
5. The p38-MITOGEN-ACTIVATED PROTEIN KINASE Signaling Pathway Is Involved in
Lin JH; Hung CH; Huang YC; Chen CS; Ho DR
Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895809
[TBL] [Abstract][Full Text] [Related]
6. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
[TBL] [Abstract][Full Text] [Related]
7. [Expression of IκBα in bladder cancer cell lines is negatively correlated with epithelial-mesenchymal transition and cell invasion in vitro].
Wang X; Cheng H; Chen Y; Li H; He D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1159-61. PubMed ID: 25374080
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice.
Dinney CP; Fishbeck R; Singh RK; Eve B; Pathak S; Brown N; Xie B; Fan D; Bucana CD; Fidler IJ
J Urol; 1995 Oct; 154(4):1532-8. PubMed ID: 7658585
[TBL] [Abstract][Full Text] [Related]
9. An investigation into the cytotoxic effects of 13-acetoxysarcocrassolide from the soft coral Sarcophyton crassocaule on bladder cancer cells.
Su CC; Su JH; Lin JJ; Chen CC; Hwang WI; Huang HH; Wu YJ
Mar Drugs; 2011 Dec; 9(12):2622-2642. PubMed ID: 22363243
[TBL] [Abstract][Full Text] [Related]
10. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
11. Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.
Gildea JJ; Golden WL; Harding MA; Theodorescu D
Genes Chromosomes Cancer; 2000 Mar; 27(3):252-63. PubMed ID: 10679914
[TBL] [Abstract][Full Text] [Related]
12. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynold LM
Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
[TBL] [Abstract][Full Text] [Related]
13. Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines.
Bindels EM; Vermey M; De Both NJ; van der Kwast TH
Virchows Arch; 2001 Oct; 439(4):552-9. PubMed ID: 11710643
[TBL] [Abstract][Full Text] [Related]
14. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
15. Novel ZEB1 expression in bladder tumorigenesis.
Kenney PA; Wszolek MF; Rieger-Christ KM; Neto BS; Gould JJ; Harty NJ; Mosquera JM; Zeheb R; Loda M; Darling DS; Libertino JA; Summerhayes IC
BJU Int; 2011 Feb; 107(4):656-63. PubMed ID: 20735391
[TBL] [Abstract][Full Text] [Related]
16. Effects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cells.
Hänze J; Kessel F; Di Fazio P; Hofmann R; Hegele A
Biomed Pharmacother; 2018 Oct; 106():316-325. PubMed ID: 29966976
[TBL] [Abstract][Full Text] [Related]
17. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynolds LM
J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
[TBL] [Abstract][Full Text] [Related]
18. The importance of integrin-linked kinase in the regulation of bladder cancer invasion.
Matsui Y; Assi K; Ogawa O; Raven PA; Dedhar S; Gleave ME; Salh B; So AI
Int J Cancer; 2012 Feb; 130(3):521-31. PubMed ID: 21351095
[TBL] [Abstract][Full Text] [Related]
19. Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression.
Rieger KM; Little AF; Swart JM; Kastrinakis WV; Fitzgerald JM; Hess DT; Libertino JA; Summerhayes IC
Br J Cancer; 1995 Sep; 72(3):683-90. PubMed ID: 7669581
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming bladder cancer cells for studying cancer initiation and progression.
Iskender B; Izgi K; Canatan H
Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
